Through digital twin technology, we identify condition-specific metabolic targets and design research-backed, food-grade microbiome formulations to support outcomes across gastrointestinal, ocular, urological, cognitive, mental health and beyond.
Human gut microbiota + Digital twin technology x Artificial intelligence = Next-Generation Nutraceuticals
Human gut microbiota + Digital twin technology x Artificial intelligence = Next-Generation Nutraceuticals
Human Gut Microbiota
The human gut microbiota is a dynamic biological ecosystem that transforms food into bioactive metabolites. We start by characterizing microbial composition and metabolic capacity, treating the microbiome as a living system that can be guided—not overridden.
Digital Twin Technology
We create digital twins of real human microbiomes to simulate how specific ingredients are metabolized. This allows us to identify condition-specific key metabolites and trace them back to feasible, food-grade nutritional precursors—before entering the clinic or production.
Artificial Intelligence
Artificial intelligence integrates large-scale microbiome data, metabolic networks, and literature-validated mechanisms. By modeling thousands of scenarios in silico, AI enables us to design targeted, research-backed nutraceutical formulations with predictable biological outcomes.
Next-Generation Nutraceuticals
Prediction
Microbiome data → Digital twin simulation → Metabolic flux prediction
Design
Retrosynthhesis of food-grade substrates → Minimal precusor set discovery → Personalized ingredient combinations
Our microbiome intelligence platform has been evaluated through clinical studies and peer-reviewed publications, confirming both biological relevance and translational impact.
